Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 520398132 series 2134703
Content provided by Bryn Mawr Communications (BMC). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bryn Mawr Communications (BMC) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.
99 episodes
))
